Skip to main navigation Skip to search Skip to main content

Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus

  • Melissa A. Buckley
  • , Nicholas T. Woods
  • , Jonathan P. Tyrer
  • , Gustavo Mendoza-Fandiño
  • , Kate Lawrenson
  • , Dennis J. Hazelett
  • , Hamed S. Najafabadi
  • , Anxhela Gjyshi
  • , Renato S. Carvalho
  • , Paulo C. Lyra
  • , Simon G. Coetzee
  • , Howard C. Shen
  • , Ally W. Yang
  • , Madalene A. Earp
  • , Sean J. Yoder
  • , Harvey Risch
  • , Georgia Chenevix-Trench
  • , Susan J. Ramus
  • , Catherine M. Phelan
  • , Gerhard A. Coetzee
  • Houtan Noushmehr, Timothy R. Hughes, Thomas A. Sellers, Ellen L. Goode, Paul D. Pharoah, Simon A. Gayther, Alvaro N.A. Monteiro, Y. Ann Chen, Brooke L. Fridley, Katja K.H. Aben, Lambertus A. Kiemeney, Hoda Anton-Culver, Argyrios Ziogas, Fiona Bruinsma, Roger L. Milne, Elisa V. Bandera, Graham G. Giles, Yukie T. Bean, Tanja Pejovic, Matthias W. Beckmann, Alexander Hein, Line Bjorge, Peter A. Fasching, Liv C.V. Thomsen, Reidun K. Kopperud, Katharina Bischof, Natalia Bogdanova, Thilo Dörk, Peter Hillemanns, Louise A. Brinton, Nicolas Wentzensen, Hannah Yang, Angela Brooks-Wilson, Clareann H. Bunker, Ralf Butzow, Heli Nevanlinna, Liisa M. Pelttari, Ian G. Campbell, Melissa C. Southey, Francesmary Modugno, Karen Carty, Rosalind Glasspool, Ian McNeish, James Paul, Nadeem Siddiqui, Jenny Chang-Claude, Anja Rudolph, Linda S. Cook, Daniel W. Cramer, Kathryn L. Terry, Julie M. Cunningham, Cezary Cybulski, Jacek Gronwald, Anna Jakubowska, Jan Lubinski, Agnieszka Dansonka-Mieszkowska, Jolanta Kupryjanczyk, Iwona K. Rzepecka, Andreas Du Bois, Philipp Harter, Ed Dicks, Honglin Song, Jennifer A. Doherty, Mary Anne Rossing, Matthias Dürst, Douglas F. Easton, Diana M. Eccles, Robert P. Edwards, Arif B. Ekici, Yu Tang Gao, Aleksandra Gentry-Maharaj, Marc T. Goodman, Pamela J. Thompson, Hanis N. Hasmad, Soo Hwang Teo, Michelle A.T. Hildebrandt, Xifeng Wu, Estrid Hogdall, Allan Jensen, Susanne K. Kjaer, Edwin S. Iversen, Beth Y. Karlan, Jenny Lester, Sandra Orsulic, Christine S. Walsh, Joseph L. Kelley, Diether Lambrechts, Sandrina Lambrechts, Ignace Vergote, Alice W. Lee, Douglas A. Levine, Dong Liang, Jolanta Lissowska, Karen Lu, Lene Lundvall, Leon F.A.G. Massuger, Anne M. Van Altena, Keitaro Matsuo, Valerie McGuire, John R. McLaughlin, Usha Menon, Kirsten B. Moysich, Roberta B. Ness, Kunle Odunsi, Sara H. Olson, Irene Orlow, Malcolm C. Pike, Celeste L. Pearce, Anna H. Wu, Jennifer B. Permuth, Ya Yu Tsai, Shelley S. Tworoger, Elizabeth M. Poole, Barry Rosen, Xiao Ou Shu, Yurii B. Shvetsov, Lynne R. Wilkens, Weiva Sieh, Beata Spiewankiewicz, Lara Sucheston-Campbell, Lotte Thomsen, Shan Wang-Gohrke, Alice S. Whittemore, Yin Ling Woo, Wei Zheng, Andrew Berchuck, Joellen M. Schildkraut, Linda E. Kelemen, Matthew L. Freedman
  • Moffitt Cancer Center
  • University of South Florida
  • University of Cambridge
  • Cedars-Sinai Medical Center
  • University of Southern California
  • University of Toronto
  • McGill University
  • Mayo Clinic Rochester, MN
  • Yale University
  • Queensland Institute of Medical Research
  • University of New South Wales
  • Garvan Institute of Medical Research
  • Van Andel Institute
  • Henry Ford Health System
  • Canadian Institute for Advanced Research
  • Radboud University Nijmegen
  • Netherlands Comprehensive Cancer Organization
  • University of California at Irvine
  • Cancer Council Victoria
  • University College London
  • Rutgers - The State University of New Jersey, New Brunswick
  • University of Melbourne
  • Oregon Health and Science University
  • Friedrich-Alexander University Erlangen-Nürnberg
  • University of Bergen
  • University of California at Los Angeles
  • Hannover Medical School
  • National Institutes of Health
  • Provincial Health Services Authority
  • Simon Fraser University
  • University of Pittsburgh
  • University of Helsinki
  • Helsinki University Hospital
  • Peter Maccallum Cancer Centre
  • KU Leuven
  • NHS Greater Glasgow and Clyde
  • Beatson Oncology Centre
  • German Cancer Research Center
  • University of Hamburg
  • University of New Mexico
  • Brigham and Women’s Hospital
  • Harvard University
  • Pomeranian Medical University in Szczecin
  • Maria Sklodowska-Curie Institute of Oncology
  • Kliniken Essen-Mitte
  • Dr. Horst Schmidt Klinik GmbH
  • Dartmouth College
  • University of Washington
  • Friedrich Schiller University Jena
  • University Hospital Southampton NHS Foundation Trust
  • Shanghai Cancer Institute
  • Sime Darby Medical Centre
  • University of Malaya
  • University of Texas MD Anderson Cancer Center
  • Danish Cancer Society
  • University of Copenhagen
  • Duke University
  • California State University Fullerton
  • New York University
  • Texas Southern University
  • Aichi Cancer Center Hospital and Research Institute
  • Stanford University
  • Public Health Ontario
  • University of Texas Health Science Center at Houston
  • Roswell Park Cancer Institute
  • Memorial Sloan-Kettering Cancer Center
  • University of Michigan, Ann Arbor
  • Vanderbilt University
  • University of Hawai'i at Mānoa
  • Icahn School of Medicine at Mount Sinai
  • Ohio State University
  • Ulm University
  • University of Virginia
  • Medical University of South Carolina
  • Dana-Farber Cancer Institute

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Genome-wide association studies have identified 40 ovarian cancer risk loci. However, the mechanisms underlying these associations remain elusive. In this study, we conducted a two-pronged approach to identify candidate causal SNPs and assess underlying biological mechanisms at chromosome 9p22.2, the first and most statistically significant associated locus for ovarian cancer susceptibility. Three transcriptional regulatory elements with allele-specific effects and a scaffold/matrix attachment region were characterized and, through physical DNA interactions, BNC2 was established as the most likely target gene. We determined the consensus binding sequence for BNC2 in vitro, verified its enrichment in BNC2 ChIP-seq regions, and validated a set of its downstream target genes. Fine-mapping by dense regional genotyping in over 15,000 ovarian cancer cases and 30,000 controls identified SNPs in the scaffold/matrix attachment region as among the most likely causal variants. This study reveals a comprehensive regulatory landscape at 9p22.2 and proposes a likely mechanism of susceptibility to ovarian cancer.

Original languageEnglish
Pages (from-to)467-481
Number of pages15
JournalCancer Research
Volume79
Issue number3
DOIs
StatePublished - Feb 1 2019

Fingerprint

Dive into the research topics of 'Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus'. Together they form a unique fingerprint.

Cite this